Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
A new biotech blooms with $100M to take on small molecules
BlossomHill Therapeutics has raised $100 million in a series B financing, bringing the company’s total fundraising to $173 million so far.
Annalee Armstrong
Feb 29, 2024 9:30am
Ono taps Shattuck for $227M bifunctional fusion protein deal
Feb 13, 2024 8:29am
Kyverna CEO: 'We're in the next phase of medicine'
Feb 9, 2024 1:57pm
Kyverna raises IPO expectations to almost $300M
Feb 6, 2024 9:46am
Kyverna eyes $180M IPO haul to fund autoimmune CAR-T trials
Feb 1, 2024 9:45am
Novartis dances into JPM with $250M Calypso buyout, 2 more deals
Jan 8, 2024 6:28am